Crisis Management for a Conflict with North Korea
This is the best North Korea conflict crisis support available today. Predict, plan, build, prepare, train, and test in the right way.
Cordlife ordered to stop collecting new cord blood after failing to meet MOH requirements
Channel News Asia | English | News | Nov. 28, 2025 | Regulatory Enforcement Actions
From November 26, 2025, Cordlife Group has been suspended by Singapore's Ministry of Health (MOH) from collecting, testing, processing, or storing new cord blood units (CBUs). The company is only permitted to maintain the storage of existing CBUs and carry out limited actions such as transferring or disposing of these units according to clients' instructions.
MOH had previously issued Cordlife a notice of intent to suspend its cord blood banking services for one year in September 2025 after a follow-up audit in July identified lapses in the collection, processing, and testing of 160 new CBUs, as well as failures in governance, incident reporting, and management. Despite giving Cordlife 14 days to respond, MOH concluded that the company did not adequately address the concerns and requires more time to resolve outstanding issues.
The regulatory action, which will remain in effect even if Cordlife's licence is renewed in January 2026, also requires the company to replace its clinical governance officer and review all laboratory records of the 160 CBUs collected since January 2025. MOH stressed that it will continue close supervision and may impose further sanctions if additional non-compliance is found.
Cordlife's problems began in November 2023 when MOH revealed tanks storing cord blood units had been exposed to unacceptable temperatures, resulting in over 7,400 non-viable units across two incidents affecting thousands of clients. Although Cordlife was allowed to resume limited operations in September 2024, repeated compliance failures have led to the current suspension.